胰腺头部实性病变的超声造影:一项前瞻性研究
这项前瞻性研究纳入98例胰腺头部实性病变患者,评估超声造影(CEUS)在鉴别诊断中的作用。结果显示低增强、不完全增强和向心性增强在胰腺导管腺癌(PDAC)中更常见,而中央血管在非PDAC病变中更常见。CEUS可用于鉴别PDAC与非PDAC病变,并可纳入诊断流程。
要点
- CEUS上低增强、不完全增强和向心性增强在PDAC中显著更常见。
- CEUS上中央血管存在在非PDAC病变中显著更多见。
- 低增强且增强程度<30%诊断PDAC的敏感度为80.6%、特异度为67.7%。
核心结论
- CEUS是评估胰腺头部实性病变的有用工具,可纳入诊断流程以鉴别PDAC与非PDAC病变。
研究设计与样本
- 前瞻性研究,连续纳入98例胰腺头部实性病变患者,行胰腺CEUS评估,最终诊断基于组织病理学或细胞学。
关键影像表现/征象
- 低增强、不完全增强和向心性增强在PDAC中显著多于非PDAC病变(p=0.001、p=0.031、p=0.002)。
- 中央血管在非PDAC病变中显著更多见(p=0.0001)。
- PDAC与非PDAC病变的达峰时间(TTP)和消退时间(WT)无显著差异。
- PDAC的WT显著短于NET(p=0.011)。
诊断标准与关键数值
- 低增强且CEUS增强程度<30%诊断PDAC的敏感度为80.6%、特异度为67.7%。
- 多因素分析显示缺乏中央血管与PDAC诊断显著相关。
临床应用与阅片要点
- 观察CEUS增强程度、增强完整性、向心性增强及中央血管有助于鉴别PDAC与非PDAC病变。
- 低增强且增强程度<30%对PDAC有提示价值(敏感度80.6%、特异度67.7%)。
- TTP和WT在PDAC与非PDAC病变间无显著差异,但PDAC的WT显著短于NET(p=0.011)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the role of contrast-enhanced ultrasound (CEUS) in the differential diagnosis of solid pancreatic head lesions (SPHL).
METHODS: This prospective study comprised consecutive patients with SPHL who underwent CEUS evaluation of the pancreas. Findings recorded at CEUS were enhancement patterns (degree, completeness, centripetal enhancement, and percentage enhancement) and presence of central vessels. In addition, time to peak (TTP) and washout time (WT) were recorded. The final diagnosis was based on histopathology or cytology. Multivariate analysis was performed to identify parameters that were significantly associated with pancreatic ductal adenocarcinoma (PDAC).
RESULTS: Ninety-eight patients (median age 53.8 years, 59 males) were evaluated. The final diagnosis was PDAC (n = 64, 65.3%), inflammatory mass (n = 16, 16.3%), neuroendocrine tumor (NET, n = 14, 14.3%), and other tumors (n = 4, 4.1%). Hypoenhancement, incomplete enhancement, and centripetal enhancement were significantly more common in PDAC than non-PDAC lesions (p = 0.001, p = 0.031, and p = 0.002, respectively). Central vessels were present in a significantly greater number of non-PDAC lesions (p = 0.0001). Hypoenhancement with < 30% enhancement at CEUS had sensitivity and specificity of 80.6% and 67.7%, respectively, for PDAC. There was no significant difference in the TTP and WT between PDAC and non - PDAC lesions. However, the WT was significantly shorter in PDAC compared to NET (p = 0.011). In multivariate analysis, lack of central vessels was significantly associated with a PDAC diagnosis.
CONCLUSION: CEUS is a useful tool for the evaluation of SPHL. CEUS can be incorporated into the diagnostic algorithm to differentiate PDAC from non-PDAC lesions.
KEY POINTS: • Hypoenhancement and incomplete enhancement at CEUS were significantly more common in PDAC than in non-PDAC. • Central vessels at CEUS were significantly associated with PDAC. • There was no difference in TTP and WT between PDAC and non-PDAC lesions.
引用
- Gupta, Rana, Marodia, et al. Contrast-enhanced ultrasound of solid pancreatic head lesions: a prospective study. Eur Radiol. 2022. PMID: 35587829. doi:10.1007/s00330-022-08854-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。